Unaggressive PC | Aggressive PC (not advanced) | Aggressive PC (advanced) | ||
---|---|---|---|---|
Diagnoses and health-related conditions2 | ||||
Total ND | 147,743 | 10,759 | 16,874 | |
Mean ND per patient | 23.3a | 25.6a | 24.6a | |
Mean ND per patient (excluding outlier patients)3 | 14.8a | 14.4a | 16.2b | |
Median ND per patient | 12a | 12a | 14b | |
Npatients (% of patients) with ≥ 1 code | 5972(94.2%)a | 390(92.6%)a | 664(96.8%)b | |
Total ND (unrepeated for each patient) | 41,373 | 2963 | 4928 | |
Mean ND per patient (unrepeated for each patient) | 6.52a | 7.04ab | 7.18b | |
Median ND per patient (unrepeated for each patient) | 5a | 5a | 6b | |
Biochemistry analyses and biomarkers | ||||
Total Nanalyses | 43,263 | 3485 | 5731 | |
Mean Nanalyses per patient | 6.8a | 8.3b | 8.4b | |
Mean Nanalyses per patient (excluding outlier patients)3 | 4.0a | 4.1a | 5.1b | |
Median Nanalyses per patient | 3a | 3a | 3a | |
Total Nbiomarkers | 545,347 | 45,057 | 71,569 | |
Mean Nbiomarkers per patient | 86.0a | 107b | 104b | |
Mean Nbiomarkers per patient (excluding outlier patients)3 | 44.8a | 44.7a | 63.2b | |
Median Nbiomarkers per patient | 25a | 33ab | 38b | |
Operations and investigations4 | ||||
Total NOI | 485 | 34 | 55 | |
Mean NOI per patient | 0.076a | 0.081a | 0.080a | |
Median NOI per patient5 | 0a | 0a | 0a | |
Npatients (% of patients) with ≥ 1 code | 144(2.27%)a | 12(2.85%)a | 19(2.77%)a | |
Total NOI (unrepeated for each patient) | 191 | 15 | 23 | |
Mean NOI per patient (unrepeated for each patient) | 0.030a | 0.036a | 0.034a | |
Median NOI per patient (unrepeated for each patient)5 | 0a | 0a | 0a | |
Specific prostate investigations | ||||
Ultrasound | Mean | 0.47a | 0.38b | 0.34b |
N (%) investigations | 2954 (46.6%)a | 161 (38.2%)b | 234 (34.1%)b | |
N (%) patients with ≥ 1 | 2415 (38.1%)a | 146 (34.7%)ab | 216 (31.5%)b | |
Biopsy | Mean | 0.58a | 0.44b | 0.43b |
N (%) biopsies | 3676 (58.1%)a | 187 (44.2%)b | 294 (42.9%)b | |
N (%) patients with ≥ 1 | 3125 (49.3%)a | 179 (42.5%)b | 282 (41.1%)b |